azane;[7-(1,3-benzothiazol-6-yl)-3a,9b-dihydro-3H-pyrazolo[4,3-f]quinolin-9-yl] formate;(2E)-N-[(2Z,5E)-4,9-dihydro-1H-diazonin-6-yl]-1-(3-ethenyl-4-methanimidoylphenyl)-2-ethylidenepentan-1-imine;N-[(Z)-[(E)-4-[[(E)-1-(3,4-dihydroisoquinolin-8-yl)but-2-enylidene]amino]but-3-enylidene]amino]prop-2-en-1-amine;7-[(E)-2-(3-ethenyl-4-pyridinyl)ethenyl]-6,7,8,9,10,11-hexahydro-3H-pyrazolo[4,5-a]phenanthridine;propane;N-[(Z)-2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]ethenyl]methanimine;hydrochloride

C110H118ClN21O2S — CID 172916962

IUPACazane;[7-(1,3-benzothiazol-6-yl)-3a,9b-dihydro-3H-pyrazolo[4,3-f]quinolin-9-yl] formate;(2E)-N-[(2Z,5E)-4,9-dihydro-1H-diazonin-6-yl]-1-(3-ethenyl-4-methanimidoylphenyl)-2-ethylidenepentan-1-imine;N-[(Z)-[(E)-4-[[(E)-1-(3,4-dihydroisoquinolin-8-yl)but-2-enylidene]amino]but-3-enylidene]amino]prop-2-en-1-amine;7-[(E)-2-(3-ethenyl-4-pyridinyl)ethenyl]-6,7,8,9,10,11-hexahydro-3H-pyrazolo[4,5-a]phenanthridine;propane;N-[(Z)-2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]ethenyl]methanimine;hydrochloride
SMILESC=CCN/N=C\C/C=C/N=C(\C=C\C)c1cccc2c1C=NCC2.C=Cc1cnccc1/C=C/C1Nc2ccc3[nH]ncc3c2C2=C1CCCC2.C=N/C=C\c1ccc(-c2nc3ccc4[nH]ncc4c3c3c2CCCC3)cc1.CCC.Cl.N.O=COc1cc(-c2ccc3ncsc3c2)nc2c1C1C=NNC1C=C2.[H]/N=C/c1ccc(C(=N/C2=C/C/C=N\NCC=C2)/C(=C/C)CCC)cc1C=C
InChIInChI=1S/C23H20N4.C23H22N4.C23H28N4.C20H24N4.C18H12N4O2S.C3H8.ClH.H3N/c1-24-13-12-15-6-8-16(9-7-15)23-18-5-3-2-4-17(18)22-19-14-25-27-20(19)10-11-21(22)26-23;1-2-15-13-24-12-11-16(15)7-8-20-17-5-3-4-6-18(17)23-19-14-25-27-21(19)9-10-22(23)26-20;1-4-9-18(5-2)23(20-12-13-21(17-24)19(6-3)16-20)27-22-10-7-14-25-26-15-8-11-22;1-3-8-20(22-13-5-6-14-24-23-12-4-2)18-10-7-9-17-11-15-21-16-19(17)18;23-9-24-16-6-15(10-1-2-13-17(5-10)25-8-19-13)21-14-4-3-12-11(18(14)16)7-20-22-12;1-3-2;;/h6-14H,1-5H2,(H,25,27);2,7-14,20,26H,1,3-6H2,(H,25,27);5-7,10-13,15-17,24-25H,3-4,8-9,14H2,1-2H3;3-5,7-10,13-14,16,23H,2,6,11-12,15H2,1H3;1-9,11-12,22H;3H2,1-2H3;1H;1H3/b13-12-;8-7+;10-7?,18-5+,22-11+,24-17+,26-15-,27-23+;8-3+,13-5+,22-20+,24-14-;;;;
InChIKeyMWJCLWZSYLVQMX-VXMWALNWSA-N
MW1833.82 g/mol
LogP24.70
Rot. Bonds24

About azane;[7-(1,3-benzothiazol-6-yl)-3a,9b-dihydro-3H-pyrazolo[4,3-f]quinolin-9-yl] formate;(2E)-N-[(2Z,5E)-4,9-dihydro-1H-diazonin-6-yl]-1-(3-ethenyl-4-methanimidoylphenyl)-2-ethylidenepentan-1-imine;N-[(Z)-[(E)-4-[[(E)-1-(3,4-dihydroisoquinolin-8-yl)but-2-enylidene]amino]but-3-enylidene]amino]prop-2-en-1-amine;7-[(E)-2-(3-ethenyl-4-pyridinyl)ethenyl]-6,7,8,9,10,11-hexahydro-3H-pyrazolo[4,5-a]phenanthridine;propane;N-[(Z)-2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]ethenyl]methanimine;hydrochloride

azane;[7-(1,3-benzothiazol-6-yl)-3a,9b-dihydro-3H-pyrazolo[4,3-f]quinolin-9-yl] formate;(2E)-N-[(2Z,5E)-4,9-dihydro-1H-diazonin-6-yl]-1-(3-ethenyl-4-methanimidoylphenyl)-2-ethylidenepentan-1-imine;N-[(Z)-[(E)-4-[[(E)-1-(3,4-dihydroisoquinolin-8-yl)but-2-enylidene]amino]but-3-enylidene]amino]prop-2-en-1-amine;7-[(E)-2-(3-ethenyl-4-pyridinyl)ethenyl]-6,7,8,9,10,11-hexahydro-3H-pyrazolo[4,5-a]phenanthridine;propane;N-[(Z)-2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]ethenyl]methanimine;hydrochloride (PubChem CID 172916962) has the molecular formula C110H118ClN21O2S and a molecular weight of 1833.82 g/mol. Its IUPAC name is azane;[7-(1,3-benzothiazol-6-yl)-3a,9b-dihydro-3H-pyrazolo[4,3-f]quinolin-9-yl] formate;(2E)-N-[(2Z,5E)-4,9-dihydro-1H-diazonin-6-yl]-1-(3-ethenyl-4-methanimidoylphenyl)-2-ethylidenepentan-1-imine;N-[(Z)-[(E)-4-[[(E)-1-(3,4-dihydroisoquinolin-8-yl)but-2-enylidene]amino]but-3-enylidene]amino]prop-2-en-1-amine;7-[(E)-2-(3-ethenyl-4-pyridinyl)ethenyl]-6,7,8,9,10,11-hexahydro-3H-pyrazolo[4,5-a]phenanthridine;propane;N-[(Z)-2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]ethenyl]methanimine;hydrochloride.

Molecular Properties

Compound Nameazane;[7-(1,3-benzothiazol-6-yl)-3a,9b-dihydro-3H-pyrazolo[4,3-f]quinolin-9-yl] formate;(2E)-N-[(2Z,5E)-4,9-dihydro-1H-diazonin-6-yl]-1-(3-ethenyl-4-methanimidoylphenyl)-2-ethylidenepentan-1-imine;N-[(Z)-[(E)-4-[[(E)-1-(3,4-dihydroisoquinolin-8-yl)but-2-enylidene]amino]but-3-enylidene]amino]prop-2-en-1-amine;7-[(E)-2-(3-ethenyl-4-pyridinyl)ethenyl]-6,7,8,9,10,11-hexahydro-3H-pyrazolo[4,5-a]phenanthridine;propane;N-[(Z)-2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]ethenyl]methanimine;hydrochloride
PubChem CID172916962
Molecular FormulaC110H118ClN21O2S
Molecular Weight1833.82 g/mol
Exact Mass1831.92
IUPAC Nameazane;[7-(1,3-benzothiazol-6-yl)-3a,9b-dihydro-3H-pyrazolo[4,3-f]quinolin-9-yl] formate;(2E)-N-[(2Z,5E)-4,9-dihydro-1H-diazonin-6-yl]-1-(3-ethenyl-4-methanimidoylphenyl)-2-ethylidenepentan-1-imine;N-[(Z)-[(E)-4-[[(E)-1-(3,4-dihydroisoquinolin-8-yl)but-2-enylidene]amino]but-3-enylidene]amino]prop-2-en-1-amine;7-[(E)-2-(3-ethenyl-4-pyridinyl)ethenyl]-6,7,8,9,10,11-hexahydro-3H-pyrazolo[4,5-a]phenanthridine;propane;N-[(Z)-2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]ethenyl]methanimine;hydrochloride
SMILESC=CCN/N=C\C/C=C/N=C(\C=C\C)c1cccc2c1C=NCC2.C=Cc1cnccc1/C=C/C1Nc2ccc3[nH]ncc3c2C2=C1CCCC2.C=N/C=C\c1ccc(-c2nc3ccc4[nH]ncc4c3c3c2CCCC3)cc1.CCC.Cl.N.O=COc1cc(-c2ccc3ncsc3c2)nc2c1C1C=NNC1C=C2.[H]/N=C/c1ccc(C(=N/C2=C/C/C=N\NCC=C2)/C(=C/C)CCC)cc1C=C
InChIInChI=1S/C23H20N4.C23H22N4.C23H28N4.C20H24N4.C18H12N4O2S.C3H8.ClH.H3N/c1-24-13-12-15-6-8-16(9-7-15)23-18-5-3-2-4-17(18)22-19-14-25-27-20(19)10-11-21(22)26-23;1-2-15-13-24-12-11-16(15)7-8-20-17-5-3-4-6-18(17)23-19-14-25-27-21(19)9-10-22(23)26-20;1-4-9-18(5-2)23(20-12-13-21(17-24)19(6-3)16-20)27-22-10-7-14-25-26-15-8-11-22;1-3-8-20(22-13-5-6-14-24-23-12-4-2)18-10-7-9-17-11-15-21-16-19(17)18;23-9-24-16-6-15(10-1-2-13-17(5-10)25-8-19-13)21-14-4-3-12-11(18(14)16)7-20-22-12;1-3-2;;/h6-14H,1-5H2,(H,25,27);2,7-14,20,26H,1,3-6H2,(H,25,27);5-7,10-13,15-17,24-25H,3-4,8-9,14H2,1-2H3;3-5,7-10,13-14,16,23H,2,6,11-12,15H2,1H3;1-9,11-12,22H;3H2,1-2H3;1H;1H3/b13-12-;8-7+;10-7?,18-5+,22-11+,24-17+,26-15-,27-23+;8-3+,13-5+,22-20+,24-14-;;;;
InChIKeyMWJCLWZSYLVQMX-VXMWALNWSA-N
XLogP24.70
TPSA328.71 Ų
H-Bond Donors8
H-Bond Acceptors22
Rotatable Bonds24
Heavy Atoms135
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001833.82
LogP ≤ 524.70
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze azane;[7-(1,3-benzothiazol-6-yl)-3a,9b-dihydro-3H-pyrazolo[4,3-f]quinolin-9-yl] formate;(2E)-N-[(2Z,5E)-4,9-dihydro-1H-diazonin-6-yl]-1-(3-ethenyl-4-methanimidoylphenyl)-2-ethylidenepentan-1-imine;N-[(Z)-[(E)-4-[[(E)-1-(3,4-dihydroisoquinolin-8-yl)but-2-enylidene]amino]but-3-enylidene]amino]prop-2-en-1-amine;7-[(E)-2-(3-ethenyl-4-pyridinyl)ethenyl]-6,7,8,9,10,11-hexahydro-3H-pyrazolo[4,5-a]phenanthridine;propane;N-[(Z)-2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]ethenyl]methanimine;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

9-cyclohexyl-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;5-fluoro-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;[7-(2-methyl-1,3-benzothiazol-6-yl)-3H-pyrazolo[4,5-f]quinolin-9-yl] formate;8-(5-methyl-2H-pyrrol-4-yl)-5-oxa-9,14,15-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(10),2(7),8,11,13(17),15-hexaene;7-(5-methyl-2H-pyrrol-4-yl)-9-pyridin-2-yl-3H-pyrazolo[4,5-f]quinoline;6-(9-methyl-3,8,10,11-tetrahydroindazolo[5,4-c][2,7]naphthyridin-7-yl)-1,3-benzothiazol-2-amine
CID 158324511
5-fluoro-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;[7-(2-methyl-1,3-benzothiazol-6-yl)-3H-pyrazolo[4,5-f]quinolin-9-yl] formate;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;7-(5-methyl-2H-pyrrol-4-yl)-9-pyridin-2-yl-3H-pyrazolo[4,5-f]quinoline
CID 158939510
9-cyclohexyl-7-(5-methyl-2H-pyrrol-4-yl)-3H-pyrazolo[4,5-f]quinoline;5-fluoro-7-(5-methyl-2H-pyrrol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;[7-(2-methyl-1,3-benzothiazol-6-yl)-3H-pyrazolo[4,5-f]quinolin-9-yl] formate;2-methyl-6-(9-methyl-3,8,10,11-tetrahydroindazolo[5,4-c][2,7]naphthyridin-7-yl)-1,3-benzothiazole;8-(5-methyl-2H-pyrrol-4-yl)-5-oxa-9,14,15-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(10),2(7),8,11,13(17),15-hexaene;7-(5-methyl-2H-pyrrol-4-yl)-9-pyridin-2-yl-3H-pyrazolo[4,5-f]quinoline
CID 164052327
[7-(2-methyl-1,3-benzothiazol-6-yl)-3H-pyrazolo[4,5-f]quinolin-9-yl] formate
CID 158324512

Frequently Asked Questions

What is the IUPAC name of azane;[7-(1,3-benzothiazol-6-yl)-3a,9b-dihydro-3H-pyrazolo[4,3-f]quinolin-9-yl] formate;(2E)-N-[(2Z,5E)-4,9-dihydro-1H-diazonin-6-yl]-1-(3-ethenyl-4-methanimidoylphenyl)-2-ethylidenepentan-1-imine;N-[(Z)-[(E)-4-[[(E)-1-(3,4-dihydroisoquinolin-8-yl)but-2-enylidene]amino]but-3-enylidene]amino]prop-2-en-1-amine;7-[(E)-2-(3-ethenyl-4-pyridinyl)ethenyl]-6,7,8,9,10,11-hexahydro-3H-pyrazolo[4,5-a]phenanthridine;propane;N-[(Z)-2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]ethenyl]methanimine;hydrochloride?
The IUPAC name of azane;[7-(1,3-benzothiazol-6-yl)-3a,9b-dihydro-3H-pyrazolo[4,3-f]quinolin-9-yl] formate;(2E)-N-[(2Z,5E)-4,9-dihydro-1H-diazonin-6-yl]-1-(3-ethenyl-4-methanimidoylphenyl)-2-ethylidenepentan-1-imine;N-[(Z)-[(E)-4-[[(E)-1-(3,4-dihydroisoquinolin-8-yl)but-2-enylidene]amino]but-3-enylidene]amino]prop-2-en-1-amine;7-[(E)-2-(3-ethenyl-4-pyridinyl)ethenyl]-6,7,8,9,10,11-hexahydro-3H-pyrazolo[4,5-a]phenanthridine;propane;N-[(Z)-2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]ethenyl]methanimine;hydrochloride (CID 172916962) is azane;[7-(1,3-benzothiazol-6-yl)-3a,9b-dihydro-3H-pyrazolo[4,3-f]quinolin-9-yl] formate;(2E)-N-[(2Z,5E)-4,9-dihydro-1H-diazonin-6-yl]-1-(3-ethenyl-4-methanimidoylphenyl)-2-ethylidenepentan-1-imine;N-[(Z)-[(E)-4-[[(E)-1-(3,4-dihydroisoquinolin-8-yl)but-2-enylidene]amino]but-3-enylidene]amino]prop-2-en-1-amine;7-[(E)-2-(3-ethenyl-4-pyridinyl)ethenyl]-6,7,8,9,10,11-hexahydro-3H-pyrazolo[4,5-a]phenanthridine;propane;N-[(Z)-2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]ethenyl]methanimine;hydrochloride.
What is the SMILES notation for azane;[7-(1,3-benzothiazol-6-yl)-3a,9b-dihydro-3H-pyrazolo[4,3-f]quinolin-9-yl] formate;(2E)-N-[(2Z,5E)-4,9-dihydro-1H-diazonin-6-yl]-1-(3-ethenyl-4-methanimidoylphenyl)-2-ethylidenepentan-1-imine;N-[(Z)-[(E)-4-[[(E)-1-(3,4-dihydroisoquinolin-8-yl)but-2-enylidene]amino]but-3-enylidene]amino]prop-2-en-1-amine;7-[(E)-2-(3-ethenyl-4-pyridinyl)ethenyl]-6,7,8,9,10,11-hexahydro-3H-pyrazolo[4,5-a]phenanthridine;propane;N-[(Z)-2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]ethenyl]methanimine;hydrochloride?
The canonical SMILES for azane;[7-(1,3-benzothiazol-6-yl)-3a,9b-dihydro-3H-pyrazolo[4,3-f]quinolin-9-yl] formate;(2E)-N-[(2Z,5E)-4,9-dihydro-1H-diazonin-6-yl]-1-(3-ethenyl-4-methanimidoylphenyl)-2-ethylidenepentan-1-imine;N-[(Z)-[(E)-4-[[(E)-1-(3,4-dihydroisoquinolin-8-yl)but-2-enylidene]amino]but-3-enylidene]amino]prop-2-en-1-amine;7-[(E)-2-(3-ethenyl-4-pyridinyl)ethenyl]-6,7,8,9,10,11-hexahydro-3H-pyrazolo[4,5-a]phenanthridine;propane;N-[(Z)-2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]ethenyl]methanimine;hydrochloride is C=CCN/N=C\C/C=C/N=C(\C=C\C)c1cccc2c1C=NCC2.C=Cc1cnccc1/C=C/C1Nc2ccc3[nH]ncc3c2C2=C1CCCC2.C=N/C=C\c1ccc(-c2nc3ccc4[nH]ncc4c3c3c2CCCC3)cc1.CCC.Cl.N.O=COc1cc(-c2ccc3ncsc3c2)nc2c1C1C=NNC1C=C2.[H]/N=C/c1ccc(C(=N/C2=C/C/C=N\NCC=C2)/C(=C/C)CCC)cc1C=C.
What is the InChIKey of azane;[7-(1,3-benzothiazol-6-yl)-3a,9b-dihydro-3H-pyrazolo[4,3-f]quinolin-9-yl] formate;(2E)-N-[(2Z,5E)-4,9-dihydro-1H-diazonin-6-yl]-1-(3-ethenyl-4-methanimidoylphenyl)-2-ethylidenepentan-1-imine;N-[(Z)-[(E)-4-[[(E)-1-(3,4-dihydroisoquinolin-8-yl)but-2-enylidene]amino]but-3-enylidene]amino]prop-2-en-1-amine;7-[(E)-2-(3-ethenyl-4-pyridinyl)ethenyl]-6,7,8,9,10,11-hexahydro-3H-pyrazolo[4,5-a]phenanthridine;propane;N-[(Z)-2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]ethenyl]methanimine;hydrochloride?
The InChIKey is MWJCLWZSYLVQMX-VXMWALNWSA-N. The full InChI is InChI=1S/C23H20N4.C23H22N4.C23H28N4.C20H24N4.C18H12N4O2S.C3H8.ClH.H3N/c1-24-13-12-15-6-8-16(9-7-15)23-18-5-3-2-4-17(18)22-19-14-25-27-20(19)10-11-21(22)26-23;1-2-15-13-24-12-11-16(15)7-8-20-17-5-3-4-6-18(17)23-19-14-25-27-21(19)9-10-22(23)26-20;1-4-9-18(5-2)23(20-12-13-21(17-24)19(6-3)16-20)27-22-10-7-14-25-26-15-8-11-22;1-3-8-20(22-13-5-6-14-24-23-12-4-2)18-10-7-9-17-11-15-21-16-19(17)18;23-9-24-16-6-15(10-1-2-13-17(5-10)25-8-19-13)21-14-4-3-12-11(18(14)16)7-20-22-12;1-3-2;;/h6-14H,1-5H2,(H,25,27);2,7-14,20,26H,1,3-6H2,(H,25,27);5-7,10-13,15-17,24-25H,3-4,8-9,14H2,1-2H3;3-5,7-10,13-14,16,23H,2,6,11-12,15H2,1H3;1-9,11-12,22H;3H2,1-2H3;1H;1H3/b13-12-;8-7+;10-7?,18-5+,22-11+,24-17+,26-15-,27-23+;8-3+,13-5+,22-20+,24-14-;;;;.
What are the key properties of azane;[7-(1,3-benzothiazol-6-yl)-3a,9b-dihydro-3H-pyrazolo[4,3-f]quinolin-9-yl] formate;(2E)-N-[(2Z,5E)-4,9-dihydro-1H-diazonin-6-yl]-1-(3-ethenyl-4-methanimidoylphenyl)-2-ethylidenepentan-1-imine;N-[(Z)-[(E)-4-[[(E)-1-(3,4-dihydroisoquinolin-8-yl)but-2-enylidene]amino]but-3-enylidene]amino]prop-2-en-1-amine;7-[(E)-2-(3-ethenyl-4-pyridinyl)ethenyl]-6,7,8,9,10,11-hexahydro-3H-pyrazolo[4,5-a]phenanthridine;propane;N-[(Z)-2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]ethenyl]methanimine;hydrochloride?
azane;[7-(1,3-benzothiazol-6-yl)-3a,9b-dihydro-3H-pyrazolo[4,3-f]quinolin-9-yl] formate;(2E)-N-[(2Z,5E)-4,9-dihydro-1H-diazonin-6-yl]-1-(3-ethenyl-4-methanimidoylphenyl)-2-ethylidenepentan-1-imine;N-[(Z)-[(E)-4-[[(E)-1-(3,4-dihydroisoquinolin-8-yl)but-2-enylidene]amino]but-3-enylidene]amino]prop-2-en-1-amine;7-[(E)-2-(3-ethenyl-4-pyridinyl)ethenyl]-6,7,8,9,10,11-hexahydro-3H-pyrazolo[4,5-a]phenanthridine;propane;N-[(Z)-2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]ethenyl]methanimine;hydrochloride has a molecular weight of 1833.82 g/mol, XLogP of 24.70, 24 rotatable bonds, 8 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for azane;[7-(1,3-benzothiazol-6-yl)-3a,9b-dihydro-3H-pyrazolo[4,3-f]quinolin-9-yl] formate;(2E)-N-[(2Z,5E)-4,9-dihydro-1H-diazonin-6-yl]-1-(3-ethenyl-4-methanimidoylphenyl)-2-ethylidenepentan-1-imine;N-[(Z)-[(E)-4-[[(E)-1-(3,4-dihydroisoquinolin-8-yl)but-2-enylidene]amino]but-3-enylidene]amino]prop-2-en-1-amine;7-[(E)-2-(3-ethenyl-4-pyridinyl)ethenyl]-6,7,8,9,10,11-hexahydro-3H-pyrazolo[4,5-a]phenanthridine;propane;N-[(Z)-2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]ethenyl]methanimine;hydrochloride is sourced from PubChem (CID 172916962), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).